FDA approves Cymbalta for Fibromyalgia
Wednesday, June 18, 2008 - 00:14
in Mathematics & Economics
INDIANAPOLIS, June 18 (UPI) -- Eli Lilly and Co. said the U.S. Food and Drug Administration has approved duloxetine HCl, marketed under the name Cymbalta, for fibromyalgia.